{"title":"A rare diagnosis during evaluation for metabolic dysfunction associated steatotic liver disease: Glycogen storage disease type Ia presenting during adolescence in a male with severe obesity.","authors":"Carolena Trocchia, Rachel Herdes, Jodi Gedallovich, Amrita Narang","doi":"10.1002/jpr3.70247","DOIUrl":"https://doi.org/10.1002/jpr3.70247","url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common comorbidity of pediatric obesity that predisposes patients to hepatocellular adenomas (HCAs). HCAs however are nonspecific to MASLD and warrant further evaluation. We present a case of a 16-year-old male with severe obesity, and persistently elevated liver enzymes, initially evaluated for MASLD. Imaging revealed multiple hepatic lesions consistent with HCAs, prompting further genetic evaluation. Trio exome sequencing identified biallelic variants in the glucose-6-phophatase gene, confirming a diagnosis of glycogen storage disease type Ia (GSD Ia). This case highlights the diagnostic challenge posed by overlapping features of MASLD and GSD Ia, particularly hepatic steatosis, HCAs, and metabolic syndrome. Initial management of MASLD with glucagon-like peptide-1 therapy was discontinued given risk for hypoglycemia, and the patient continues glucose monitoring and cornstarch therapy. This case emphasizes the importance of including inborn errors of metabolism in the differential diagnosis for multifocal HCAs and concerns with obesity treatments.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13691576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149279517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-16DOI: 10.1002/jpr3.70245
Rasha Abi Radi Abou Jaoudeh, Cary Sauer, Teresa Oh
{"title":"Human immunodeficiency virus infection mimicking very early onset inflammatory bowel disease.","authors":"Rasha Abi Radi Abou Jaoudeh, Cary Sauer, Teresa Oh","doi":"10.1002/jpr3.70245","DOIUrl":"10.1002/jpr3.70245","url":null,"abstract":"<p><p>Very early onset inflammatory bowel disease (VEO-IBD), defined as diagnosis before 6 years of age, is often associated with immune dysregulation and monogenic etiologies; however, infectious mimics may be overlooked in low-prevalence regions. We report a 4-year-old male with poor weight gain, intermittent diarrhea, elevated fecal calprotectin, and persistently elevated erythrocyte sedimentation rate. Endoscopy showed diffuse friable colonic mucosa, and biopsies demonstrated focal active colitis with mild crypt distortion. He was diagnosed with VEO-IBD and treated with mesalamine, infliximab, adalimumab, and upadacitinib, with incomplete response. At age 7, he was hospitalized with fever, cytopenias, and pulmonary infiltrates; human immunodeficiency virus (HIV) testing was positive, with <i>Pneumocystis jirovecii</i> pneumonia and cytomegalovirus viremia. After discontinuing immunosuppression and initiating antiretroviral therapy, gastrointestinal symptoms and inflammatory markers improved. HIV-associated colitis can closely mimic VEO-IBD, and progressive lymphopenia should prompt evaluation for secondary immunodeficiency.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-16DOI: 10.1002/jpr3.70259
Teresa Di Chio, Daniela Gattini, Christina Belza, Iram Siddiqui, Bolette Hartmann, Meghan Zoe Benchimol, Shiqi Zhang, Neil E Warner, Aleixo M Muise, Yaron Avitzur
{"title":"Novel variant and enteroendocrine hormone deficiency in a patient with proline and glutamate-rich protein with a coiled coil domain 1 (PERCC1) associated enteropathy: New diagnostic and therapeutic insights.","authors":"Teresa Di Chio, Daniela Gattini, Christina Belza, Iram Siddiqui, Bolette Hartmann, Meghan Zoe Benchimol, Shiqi Zhang, Neil E Warner, Aleixo M Muise, Yaron Avitzur","doi":"10.1002/jpr3.70259","DOIUrl":"10.1002/jpr3.70259","url":null,"abstract":"<p><p>Proline and glutamate-rich protein with a coiled coil domain 1 (PERCC1)-associated enteropathy is a rare monogenic congenital diarrhea due to defective enteroendocrine cells (EECs). We describe a 6-year-old female with intestinal failure since birth. Biopsies demonstrated normal appearing gastric mucosa on hematoxylin and eosin stains. Commercial whole-exome sequencing did not reveal clinically relevant variants. Subsequent testing, prompted by undetectable serum Gastrin, identified compound heterozygous variants in PERCC1: c.390 C > G (Y130X) and a novel c.492del (S164RfsX33) variant. Hormonal profiling showed low endogenous glucagon-like peptide (GLP)-1 and -2 levels, pre and postprandial. Immunohistochemistry showed a markedly reduced density of Gastrin containing G-cells and preserved EEC. At 5.5 years, endogenous GLP-2 deficiency supported off-label Teduglutide therapy. Baseline Parenteral Nutrition Dependency Index (PNDI) was 67%; after 16 months, PNDI decreased to 35%, with improved stool output and appetite. Congenital diarrhea with low serum levels of Gastrin, GLP-1, and -2 and abnormal G-cell staining should prompt targeted genetic analysis for PERCC1 with whole genome sequencing. Timely diagnosis enables Teduglutide therapy and parenteral nutrition weaning.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-15DOI: 10.1002/jpr3.70250
Sara Bohon, Regino Gonzalez-Peralta, Robert J Fontana, Richard Cordle, Robin LeGallo, Frank DiPaola
{"title":"Suspected fibrosing cholestatic hepatitis in an immunocompetent child with hepatitis C: Case report.","authors":"Sara Bohon, Regino Gonzalez-Peralta, Robert J Fontana, Richard Cordle, Robin LeGallo, Frank DiPaola","doi":"10.1002/jpr3.70250","DOIUrl":"10.1002/jpr3.70250","url":null,"abstract":"<p><p>A 12-year-old boy presented to our center with elevated aminotransferases, jaundice, right upper quadrant tenderness, and hepatomegaly. Evaluation revealed a highly elevated blood hepatitis C virus (HCV) ribonucleic acid (RNA) level, and liver biopsy showed canalicular and intrahepatic cholestasis, feathery degeneration of hepatocytes, and periportal/perisinusoidal fibrosis. Though there were atypical biopsy features, including absence of bile ductular reaction, we diagnosed suspected fibrosing cholestatic hepatitis (FCH). FCH secondary to HCV infection has been reported exclusively in immunosuppressed adults. To our knowledge, this is the first reported case of suspected FCH in a child, and the first reported case of suspected HCV-related FCH in any immunocompetent patient. Our patient was successfully treated with sofosbuvir/velpatasvir with sustained virologic response at 12 weeks. We conclude that FCH should be considered on the differential whenever any child with HCV infection presents with evidence of worsening liver injury including new hepatomegaly or jaundice.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670154/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Achieving clinical and histologic remission with tezepelumab in an adolescent with refractory eosinophilic gastrointestinal disease: A case report.","authors":"Destiny Newsome, Colby Sharlin, Cindy Salm Bauer, Shauna Schroeder","doi":"10.1002/jpr3.70249","DOIUrl":"10.1002/jpr3.70249","url":null,"abstract":"<p><p>Tezepelumab is a human monoclonal antibody that binds to human thymic stromal lymphopoietin (TSLP), an epithelial cytokine that plays a role in Type 2 signaling. We describe a 17-year-old with a history of eosinophilic esophagitis (EoE) and eosinophilic gastroenteritis who demonstrated response to tezepelumab with both clinical and histologic remission. The patient had previously failed multiple standard therapies, including extensive dietary elimination, topical swallowed steroids, and dupilumab, with persistent symptoms and esophageal and duodenal eosinophilia. This case underscores the importance of continued research into eosinophilic gastrointestinal diseases (EGIDs) and suggests that TSLP blockade may offer a promising therapeutic option for patients with refractory EoE and non-EoE EGIDs.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-15DOI: 10.1002/jpr3.70251
Evan Greenhall, Bri Best, David F Carpenteri, Paula Prieto-Tizzard
{"title":"More than just anemia: Uncovering celiac disease beneath the surface: A case report.","authors":"Evan Greenhall, Bri Best, David F Carpenteri, Paula Prieto-Tizzard","doi":"10.1002/jpr3.70251","DOIUrl":"10.1002/jpr3.70251","url":null,"abstract":"<p><p>Celiac disease (CD) is an immune-mediated disorder triggered by gluten in genetically susceptible individuals. Although iron deficiency anemia is a common presentation, other micronutrient deficiencies may occur. We describe a 3.5-year-old female whose initial presentation of CD was severe, asymptomatic normocytic anemia secondary to copper (Cu) deficiency. She presented with mild abdominal symptoms, weight loss, and profound anemia (hemoglobin as low as 1.6 g/dL) requiring transfusions. Extensive infectious, inflammatory, hematologic, and oncologic evaluations were unrevealing. Workup demonstrated markedly elevated celiac serologies and low serum Cu. Endoscopy confirmed Marsh 3B duodenal changes consistent with CD. Treatment with a strict gluten-free diet and Cu supplementation led to normalization of hemoglobin, Cu levels, and growth parameters. This case highlights Cu deficiency-associated anemia as a rare pediatric presentation of CD and underscores the importance of considering CD in severe unexplained anemia with micronutrient deficiencies.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-15DOI: 10.1002/jpr3.70260
Fabio Rotondo, Antonio Marseglia, Anna Locatelli, Dalila Tedeschi, Marco Gentile, Francesco Perri, Maria Rosa Pastore, Massimo Pettoello Mantovani
{"title":"Two pediatric type II achalasia cases complicated by candidal and eosinophilic esophagitis: Successful peroral endoscopic myotomy treatment.","authors":"Fabio Rotondo, Antonio Marseglia, Anna Locatelli, Dalila Tedeschi, Marco Gentile, Francesco Perri, Maria Rosa Pastore, Massimo Pettoello Mantovani","doi":"10.1002/jpr3.70260","DOIUrl":"10.1002/jpr3.70260","url":null,"abstract":"<p><p>Achalasia is a rare esophageal motility disorder in children, often leading to delayed diagnosis. We report the first two pediatric cases treated with peroral endoscopic myotomy (POEM) at our center, both classified as type II achalasia and complicated by mucosal disease. A 15-year-old girl presented with progressive dysphagia and weight loss, diagnosed with type II achalasia and Candida esophagitis. A 13-year-old boy exhibited similar symptoms with a 27-kg weight loss; histology revealed concurrent eosinophilic esophagitis. Both underwent successful POEM. These cases illustrate the clinical heterogeneity of pediatric achalasia and emphasize the importance of recognizing concomitant mucosal conditions that may delay diagnosis. POEM appears to be a safe and effective, minimally invasive treatment in the pediatric population, even in complex scenarios.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-15DOI: 10.1002/jpr3.70254
Laetitia Mouly, Tom Ruffles, Chris Smith
{"title":"Early nutritional management of cystic fibrosis infants born with meconium ileus.","authors":"Laetitia Mouly, Tom Ruffles, Chris Smith","doi":"10.1002/jpr3.70254","DOIUrl":"10.1002/jpr3.70254","url":null,"abstract":"<p><p>Meconium ileus (MI) is a well-recognised neonatal presentation of cystic fibrosis (CF) and is associated with a high nutritional risk. While nutritional management principles are outlined in international guidelines, there is limited literature describing the practical experiences of nutritional management. The aim of this communication was to describe nutritional factors observed during the first year of life in a series of MI-CF infants. Data on nine surgically managed infants were reviewed from a UK CF centre. Timelines of (i) nutritional and surgical management and (ii) growth and intake outcomes are described. Findings highlight the heterogeneity of nutritional aspects in this group and the high prevalence of acute and chronic growth failure, further supporting the requirement for close nutritional monitoring. CFTR modulator therapies have revolutionised CF management and are increasingly available at younger ages. However, as treatment is initiated well after the neonatal period and acute MI, optimising nutritional management of MI-CF infants remains a priority.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-15DOI: 10.1002/jpr3.70240
Kirby Lampe, Victoria Sarata, Aileen Har, Fernando Zapata
{"title":"A rare instance of Ogilvie syndrome in a pediatric patient with a complex medical history: A case report.","authors":"Kirby Lampe, Victoria Sarata, Aileen Har, Fernando Zapata","doi":"10.1002/jpr3.70240","DOIUrl":"10.1002/jpr3.70240","url":null,"abstract":"<p><p>Acute colonic pseudo-obstruction or Ogilvie's syndrome is an acute dilatation of the large bowel without an obstructive lesion. Symptoms include abdominal distension, nausea and vomiting, constipation, and occasional dyspnea. The disorder most commonly involves the cecum and right colon and is most frequently seen in male patients above the age of 60. It is rare for Ogilvie's to occur in the pediatric population though some infrequent instances have been reported. Here, we report a case of a patient with significant abdominal distension and gaseous distension seen on X-ray, which was diagnosed and treated as Ogilvie's syndrome. He was unresponsive to conservative and medical management and ultimately required endoscopic decompression.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13673149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JPGN reportsPub Date : 2026-10-14DOI: 10.1002/jpr3.70253
Akram Alnounou, Ajay Katwala, Mohammad Alabbas, Bisher Sawaf, Arghyadeep Ganguly, EzzElDien A Ibrahim, Fnu Vikash
{"title":"Severe constipation-associated postprandial abdominal pain in a pregnant native-liver biliary atresia survivor after Kasai portoenterostomy: A case report.","authors":"Akram Alnounou, Ajay Katwala, Mohammad Alabbas, Bisher Sawaf, Arghyadeep Ganguly, EzzElDien A Ibrahim, Fnu Vikash","doi":"10.1002/jpr3.70253","DOIUrl":"https://doi.org/10.1002/jpr3.70253","url":null,"abstract":"<p><p>An 18-year-old woman with congenital biliary atresia status post Kasai portoenterostomy and magnetic resonance imaging-reported chronic liver disease presented at 32 weeks' gestation with 6 weeks of worsening postprandial epigastric/right upper quadrant pain, nausea, and poor oral intake. Evaluation showed preserved hepatic synthetic function and no demonstrated clinically significant portal hypertension. Endoscopy excluded esophageal and gastric varices, computed tomography showed no imaging evidence of pancreatitis, biliary obstruction, or other acute intra-abdominal pathology, computed tomography angiography excluded mesenteric ischemia, and gastric emptying scintigraphy excluded gastroparesis. Nonreassuring fetal surveillance prompted preterm induction at approximately 33 weeks 4 days. Postpartum symptoms persisted, and imaging review identified severe constipation with rectal impaction/fecalization as the dominant treatable contributor. This case broadens the peripartum phenotype reported in native-liver biliary atresia survivors by emphasizing constipation-associated postprandial abdominal pain, poor oral intake, nutritional risk, and medication-related bowel dysfunction rather than variceal bleeding or hepatic decompensation alone.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13662888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149198593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}